Clinical Trial Recruitment for Breast Cancer with Genetic Modifier
A large, global pharmaceutical company enrolling a Phase 3 clinical trial in breast cancer with a genetic modifier engaged Seeker Health to create an engaging social media campaign to accelerate genetic testing, participant identification and clinical trial enrollment.
Educate women with breast cancer about the availability of this clinical trial and the opportunity to receive genetic testing
Accelerate clinical trial enrollment
Seeker Health developed a compliant Facebook campaign, focused on a subset of the Facebook user population which had previously taken actions that denoted an interest in breast cancer.
To optimize the campaign outcomes, A/B testing of images, text and targeting were implemented.
Seeker Health deployed its tool for complete comment suppression on Facebook Newsfeed Ads to mitigate risk of user-generated misinformation.
9,419 US patients engaged via Facebook advertising to begin online pre-screen
866 US patients completed online prescreen and qualified for follow up by clinical trial sites
THREE months saved from enrollment timeline